Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients
Afro-Egypt. j. infect. enem. dis
;
10(2): 174-182, 2022. tables, figures
Artículo
en Inglés
| AIM
| ID: biblio-1426356
ABSTRACT
PCR is currently the non-debatable proof for diagnosis of HCV infection as well as conclusion of treatment outcomes. HCV core antigen (HCVcAg) testing is a neglected, less expensive and less time consuming test that's presumed to achieve the same aims. The aim of this study is to find the cost-effectiveness of HCV core antigen testing in the monitoring of treatment response as an alternative to the gold-standard PCR test
Texto completo:
Disponible
Índice:
AIM (África)
Asunto principal:
Estudios Seroepidemiológicos
/
Monitoreo del Ambiente
Tipo de estudio:
Evaluación Económica en Salud
Límite:
Humanos
Idioma:
Inglés
Revista:
Afro-Egypt. j. infect. enem. dis
Año:
2022
Tipo del documento:
Artículo
Institución/País de afiliación:
Clinical pathology department, Faculty of Medicine/EG
/
Elahrar Teaching Hospital, Zagazig/EG
/
Tropical Medicine department, Faculty of Medicine/EG
Similares
MEDLINE
...
LILACS
LIS